Paper Contents
Abstract
" This article addresses the information needed to compile dossiers for different countries and the CTD format, which is anticipated to drastically cut down on the time and resources needed by the industry to create reports and applications for worldwide registration. The Common Technical Document (CTD) was created to provide a standard format for technical documentation submitted with an application for the registration of a pharmaceutical product for human use across Europe, the United States, and various Asian countries. The CTD dossier consists of five primary modules: Prescription and administrative information is covered in Module 1; overviews and summaries of Modules 35 are covered in Module 2; pharmaceutical documentation quality is covered in Module 3; non-clinical reports (pharmacologytoxicology) are covered in Module 4; and clinical study reports (clinical trials) are covered in Module 5. Each module's content is described in detail in the guidelines, and most submissions now need to use the CTD format for submission dossiers. These documents are used to assess the effectiveness of a customized drug regimen, making these details critical. They help in determining, formulating, assessing, and evaluating medication-related issues, patient-described symptoms, and conditions that the patient self-diagnoses.Keywords: Common Technical Document, Dossier.
Copyright
Copyright © 2025 Hase Sakshi Raju . This is an open access article distributed under the Creative Commons Attribution License.
